Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.
The FDA said the action recognizes the dire need for a drug to improve survival for pancreatic cancer patients, who face the ...
The Food and Drug Administration (FDA) has named Katherine Szarama to be the acting director of the unit in charge of ...
By Kamal Choudhury May 1 (Reuters) - The U.S. Food and Drug Administration has named Katherine Szarama as the acting director ...
The FDA names Katherine Szarama, PhD, as acting director of the Center for Biologics Evaluation and Research, succeeding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results